瑞财经 严明会近日,安诺优达基因科技(北京)股份有限公司(以下简称:安诺优达)向港交所提交上市申请书,联席保荐人为建银国际、国泰君安国际。安诺优达的背后站着一位著名投资人——夏佐全。2012年4月,在夏佐全的加持下,安诺优达诞生了,公司以分子诊断为核心,聚焦于IVD(体外诊断)医疗器械及多组学生命科学研究服务。相比安诺优达创始人的头衔,夏佐全有一个更为人知的身份,即比亚迪的联合创始人。1995年,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.